男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

衰老關鍵蛋白1(FBLN1)多克隆抗體

Polyclonal Antibody to Fibulin 1 (FBLN1)

  • 衰老關鍵蛋白1(FBLN1)多克隆抗體產(chǎn)品包裝(模擬)
  • 衰老關鍵蛋白1(FBLN1)多克隆抗體產(chǎn)品包裝(模擬)
  • 衰老關鍵蛋白1(FBLN1)多克隆抗體Western Blot; Sample: HepG2 cell lysate
    Primary Ab: 0.1μg/ml Rabbit Anti-Human FBLN1 Antibody
    Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate通過ISO 9001、ISO 13485質量體系認證

特異性

該抗體是針對FBLN1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別FBLN1。

用法

Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。

贈品

相關產(chǎn)品

編號適用物種：Homo sapiens (Human，人)應用(僅供研究使用，不用于臨床診斷！)
RPC472Hu02衰老關鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC472Hu03衰老關鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC472Hu01衰老關鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC472Hu02衰老關鍵蛋白1(FBLN1)多克隆抗體WB
PAC472Hu01衰老關鍵蛋白1(FBLN1)多克隆抗體WB; IHC; ICC; IP.
PAC472Hu03衰老關鍵蛋白1(FBLN1)多克隆抗體WB
FAC472Hu01抗衰老關鍵蛋白1(FBLN1)多克隆抗體Flow cytometry.
FAC472Hu03抗衰老關鍵蛋白1(FBLN1)多克隆抗體Flow cytometry.
LAC472Hu71衰老關鍵蛋白1(FBLN1)多克隆抗體(生物素標記)WB; IHC; ICC.
MAC472Hu21衰老關鍵蛋白1(FBLN1)單克隆抗體WB; IHC
MAC472Hu22衰老關鍵蛋白1(FBLN1)單克隆抗體WB; IHC
FAC472Hu02抗衰老關鍵蛋白1(FBLN1)單克隆抗體Flow cytometry.
LAC472Hu72衰老關鍵蛋白1(FBLN1)單克隆抗體(生物素標記)WB; IHC; ICC.
SEC472Hu衰老關鍵蛋白1(FBLN1)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
SCC472Hu衰老關鍵蛋白1(FBLN1)檢測試劑盒(化學發(fā)光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMC472Hu衰老關鍵蛋白1(FBLN1)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
PSC472Hu01衰老關鍵蛋白1(FBLN1)抗體對ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSC472Hu01衰老關鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志參考文獻
Clin Exp Metastasis.Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734]
Proteomics Clinical ApplicationsComparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509]
PROTEOMICS?-?Clinical?ApplicationsComparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients.[pubmed:26680509]
ENVIRONMENTAL RESEARCHExploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421]